Please Wait
Applying Filters...
menu
    • menu
    Seqens CDMO-PSE
    News
    Aether signs agreement with SEQENS for bio-based products

    22 Aug 2024

    // CNBC

    US FDA approves Mirum Pharma's genetic disorder drug

    22 Feb 2025

    // REUTERS

    Novo's Wegovy and Ozempic removed from US FDA shortage list

    22 Feb 2025

    // REUTERS

    Data Compilation
    #PharmaFlow

    Seqens

    Contact Supplier

    Website

    BioAsia

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
    Menu

    Chemoxy

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Aether signs agreement with SEQENS for bio-based products
    Aether signs agreement with SEQENS for bio-based products

    22 Aug 2024

    // CNBC

    https://www.cnbctv18.com/market/stocks/aether-industries-signs-exclusive-manufacturing-agreement-with-seqens-for-bio-based-products-19463893.htm

    CNBC
    22 Aug 2024
    Share Share